Human CD102 / ICAM-2 ELISA Kit

Research context; these publications do not establish this product's performance or suitability for a protocol.

• Antibody deficiency in myotonic dystrophy type 1: A differential diagnosis below the radar.
• Complete clinical remission of squamous cell carcinoma of the root of the tongue following treatment with envafolimab in combination with neoadjuvant chemotherapy: A case report.
• Cost-effectiveness of durvalumab consolidation therapy in limited-stage small-cell lung cancer: A Chinese and U.S. payer perspective analysis.
• Development and Characterization of a Fully Human Recombinant MPO-ANCA Monoclonal Antibody as Candidate Quality Control Material.
• A quality evaluation strategy for residual host cell proteins based on orthogonal analysis.
• Development of a colloidal gold immunochromatographic strip based on recombinant mixed antigens SAP-2 and CatL1 for rapid detection of Fasciola gigantica infection in buffaloes.
• Simplified ELISA for Detecting Antibodies to Recombinant Fusion Proteins
• ELISA Kits
• HLA ANTIBODIES DETECTED BY ELISA HTLV-III ANTIBODY KITS

Human CD102 / ICAM-2 ELISA Kit is listed in antibody-demethylase-kit. Compare catalog identities and documented specifications when evaluating products.

Products grouped by a shared documented target or catalog category; this does not establish interchangeability.

• Hexanoyl-Lysine (HEL) ELISA kit — KHL-700E